18 January 2018 | Zurich, Switzerland
PANTEC Biosolutions AG and Medical University Vienna start a Phase 1 study Comparing Laser Assisted Epidermal to Conventional Intradermal Administration of Seasonal Influenza Vaccine.
Pantec Biosolutions is the leading company for precise epidermal delivery of large weight biopharmaceuticals. Our goal is to address unmet medical needs such as to improve immunogenicity of vaccinations.
Medical CE-marked device for daily usage
The skin vaccination device
Pantec Biosolutions AG | Industriering 21 | 9491 Ruggell | Liechtenstein
© Pantec Biosolutions AG. All rights reserved.
Imprint | Disclaimer | Sitemap